|
|
||||||||
Department of Molecular Therapeutics, Osaka University Graduate School of Medicine, Osaka, Japan
NK cells are potent activators of dendritic cells (DCs), but it remains obscure how third-party cells affect the ability of NK cells to modulate DC functions. We show here that NK cells derived from healthy donors (N-NK), when cocultured with human liver epithelial cells, induced maturation as well as activation of DCs, such as increased migratory capacity as well as T cell stimulatory activity. In contrast, NK cells from chronic hepatitis C virus-infected donors (HCV-NK) were not capable of activating DCs under the same conditions. In comparison to N-NK, HCV-NK showed higher expression of CD94/NKG2A and produced IL-10 and TGF
when cultured with hepatic cells, most of which express HLA-E, a ligand for CD94/NKG2A. Blockade of NKG2A restored the ability of HCV-NK to activate DCs, which appeared to result from the reduced NK cell production of IL-10 and TGF
. The blockade also endowed HCV-NK with an ability to drive DCs to generate Th1-polarized CD4+ T cells. These findings show that NK cell modulation of DCs is regulated by third-party cells through NK receptor and its ligand interaction. Aberrant expression of NK receptors may have an impact on the magnitude and direction of DC activation of T cells under pathological conditions, such as chronic viral infection.
This article has been cited by other articles:
![]() |
E. Morel and T. Bellon HLA Class I Molecules Regulate IFN-{gamma} Production Induced in NK Cells by Target Cells, Viral Products, or Immature Dendritic Cells through the Inhibitory Receptor ILT2/CD85j J. Immunol., August 15, 2008; 181(4): 2368 - 2381. [Abstract] [Full Text] [PDF] |
||||
![]() |
L Golden-Mason, L Madrigal-Estebas, E McGrath, M J Conroy, E J Ryan, J E Hegarty, C O'Farrelly, and D G Doherty Altered natural killer cell subset distributions in resolved and persistent hepatitis C virus infection following single source exposure Gut, August 1, 2008; 57(8): 1121 - 1128. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Iannello, O. Debbeche, S. Samarani, and A. Ahmad Antiviral NK cell responses in HIV infection: II. viral strategies for evasion and lessons for immunotherapy and vaccination J. Leukoc. Biol., July 1, 2008; 84(1): 27 - 49. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Lukens, M. W. Cruise, M. G. Lassen, and Y. S. Hahn Blockade of PD-1/B7-H1 Interaction Restores Effector CD8+ T Cell Responses in a Hepatitis C Virus Core Murine Model J. Immunol., April 1, 2008; 180(7): 4875 - 4884. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Golden-Mason, N. Castelblanco, C. O'Farrelly, and H. R. Rosen Phenotypic and Functional Changes of Cytotoxic CD56pos Natural T Cells Determine Outcome of Acute Hepatitis C Virus Infection J. Virol., September 1, 2007; 81(17): 9292 - 9298. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Terrazzano, M. Sica, C. Gianfrani, G. Mazzarella, F. Maurano, B. De Giulio, S. de Saint-Mezard, D. Zanzi, L. Maiuri, M. Londei, et al. Gliadin Regulates the NK-Dendritic Cell Cross-Talk by HLA-E Surface Stabilization J. Immunol., July 1, 2007; 179(1): 372 - 381. [Abstract] [Full Text] [PDF] |
||||
![]() |
J Nattermann, G Feldmann, G Ahlenstiel, B Langhans, T Sauerbruch, and U Spengler Surface expression and cytolytic function of natural killer cell receptors is altered in chronic hepatitis C Gut, June 1, 2006; 55(6): 869 - 877. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |